{"url_path":"/sec/glsi/10-k/2026/item-15","section_key":"item-15","section_title":"Item 15 EXHIBITS, FINANCIAL STATEMENT SCHEDULES**","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-06-01","source_url":"https://www.sec.gov/Archives/edgar/data/1799788/0001493152-26-026651-index.html","accession_number":"0001493152-26-026651","cik":"0001799788","ticker":"GLSI","issuer_name":"Greenwich LifeSciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1799788/0001493152-26-026651-index.html","primary_entity_key":"0001799788","primary_entity_name":"Greenwich LifeSciences, Inc."},"word_count":536,"has_tables":true,"body_markdown":"**ITEM\n15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES**\n\n \n\n**Exhibit**\n\n**Number**\n\n \n**Description\nof Exhibit**\n\n \n \n**(a)(1)\nFinancial Statements**\n\n \n \nThe\nfinancial statements required by this item are submitted in a separate section beginning on page F-1 of this Annual Report on Form\n10-K.\n\n \n\n**(b)\nExhibits**\n\n \n\n**Exhibit**\n\n**Number**\n\n \n**Description**\n\n3.1\n \n[Second Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to Form 8-K filed on October 1, 2020)](https://www.sec.gov/Archives/edgar/data/1799788/000121390020029559/ea127545ex3-1_greenwich.htm)\n\n3.2\n \n[Second Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 to Form 8-K filed on October 1, 2020)](https://www.sec.gov/Archives/edgar/data/1799788/000121390020029559/ea127545ex3-2_greenwich.htm)\n\n4.1\n \n[Form of Underwriter Warrant (incorporated by reference to Exhibit 4.2 to Amendment No. 1 to Form S-1 filed on June 23, 2020)](https://www.sec.gov/Archives/edgar/data/1799788/000121390020015502/fs12020a1ex4-2_greenwich.htm)\n\n4.2\n \n[Description of the Registrant’s securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 (incorporated by reference to Exhibit 4.2 to Form 10-K filed on March 31, 2021).](https://www.sec.gov/Archives/edgar/data/1799788/000149315221007532/ex4-2.htm)\n\n10.1+\n \n[2019 Equity Incentive Plan (incorporated by reference to Exhibit 10.1 to Form S-1 filed on May 29, 2020)](https://www.sec.gov/Archives/edgar/data/1799788/000121390020013732/fs12020ex10-1_greenwich.htm)\n\n10.2\n \n[Form of Indemnification Agreement with directors and executive officers (incorporated by reference to Exhibit 10.2 to Form S-1 filed on May 29, 2020)](https://www.sec.gov/Archives/edgar/data/1799788/000121390020013732/fs12020ex10-2_greenwich.htm)\n\n10.3\n \n[Exclusive License Agreement between The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. and the Company (incorporated by reference to Exhibit 10.3 to Amendment No. 1 to Form S-1 filed on June 23, 2020)](https://www.sec.gov/Archives/edgar/data/1799788/000121390020015502/fs12020a1ex10-3_greenwich.htm)\n\n10.4\n \n[First Amendment to Exclusive License Agreement between The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. and the Company (incorporated by reference to Exhibit 10.4 to Amendment No. 1 to Form S-1 filed on June 23, 2020)](https://www.sec.gov/Archives/edgar/data/1799788/000121390020015502/fs12020a1ex10-4_greenwich.htm)\n\n10.5\n \n[Second Amendment to Exclusive License Agreement between The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. and the Company (incorporated by reference to Exhibit 10.5 to Amendment No. 1 to Form S-1 filed on June 23, 2020)](https://www.sec.gov/Archives/edgar/data/1799788/000121390020015502/fs12020a1ex10-5_greenwich.htm)\n\n10.6\n \n[American Arbitration Association Award of Arbitrators (incorporated by reference to Exhibit 10.6 to Amendment No. 1 to Form S-1 filed on June 23, 2020)](https://www.sec.gov/Archives/edgar/data/1799788/000121390020015502/fs12020a1ex10-6_greenwich.htm)\n\n10.7+\n \n[Employment Agreement between the Company and Snehal Patel dated September 29, 2020 (incorporated by reference to Exhibit 10.1 to Form 8-K filed on October 1, 2020)](https://www.sec.gov/Archives/edgar/data/1799788/000121390020029559/ea127545ex10-1_greenwich.htm)\n\n10.8\n \n[Registration Rights Agreement (incorporated by reference to Exhibit 10.8 to Amendment No. 1 to Form S-1 filed on June 23, 2020)](https://www.sec.gov/Archives/edgar/data/1799788/000121390020015502/fs12020a1ex10-8_greenwich.htm)\n\n19.1\n \n[Greenwich LifeSciences, Inc. Insider Trading Policy (incorporated by reference to Exhibit 19.1 to Form 10-K filed on April 15, 2025)](https://www.sec.gov/Archives/edgar/data/1799788/000164117225004819/ex19-1.htm)\n\n23.1\n \n[Consent of Malone Bailey](ex23-1.htm)\n\n24\n \n[Power of Attorney (included on signature page hereto).](#p_001)\n\n31.1\n \n[Certification of Principal Executive Officer and Principal Financial Officer required under Rule 13a-14(a)/15d-14(a) under the Exchange Act.](ex31-1.htm)\n\n32.1\n \n[Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](ex32-1.htm)\n\n97\n \n[Clawback Policy (incorporated by reference to Exhibit 97 to Form 10-K filed on April 15, 2024).](https://www.sec.gov/Archives/edgar/data/1799788/000149315224014625/ex97.htm)\n\n101.INS\n \nInline XBRL Instance Document.\n\n101.SCH\n \nInline XBRL Taxonomy Extension Schema.\n\n101.CAL\n \nInline XBRL Taxonomy Extension Calculation Linkbase.\n\n101.LAB\n \nInline XBRL Taxonomy Extension Labels Linkbase.\n\n101.PRE\n \nInline XBRL Taxonomy Extension Presentation Linkbase.\n\n101.DEF\n \nInline XBRL Taxonomy Extension Definition Linkbase.\n\n104\n \nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n+\nIndicates\na management contract or compensatory plan or arrangement."}